
### [MONDO:0000376](http://purl.obolibrary.org/obo/MONDO_0000376)
**Label:** respiratory system cancer

**Subclasses:** [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0000535](http://purl.obolibrary.org/obo/MONDO_0000535) (tonsil squamous cell carcinoma), [MONDO:0000536](http://purl.obolibrary.org/obo/MONDO_0000536) (pharynx squamous cell carcinoma), [MONDO:0003805](http://purl.obolibrary.org/obo/MONDO_0003805) (malignant pericardial mesothelioma), [MONDO:0001748](http://purl.obolibrary.org/obo/MONDO_0001748) (maxillary sinus cancer), [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0000531](http://purl.obolibrary.org/obo/MONDO_0000531) (bronchus mucoepidermoid carcinoma), [MONDO:0002831](http://purl.obolibrary.org/obo/MONDO_0002831) (non-keratinizing sinonasal squamous cell carcinoma), [MONDO:0000894](http://purl.obolibrary.org/obo/MONDO_0000894) (mucinous bronchioloalveolar adenocarcinoma), [MONDO:0001862](http://purl.obolibrary.org/obo/MONDO_0001862) (malignant visceral pleura tumor), [MONDO:0000895](http://purl.obolibrary.org/obo/MONDO_0000895) (nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0004733](http://purl.obolibrary.org/obo/MONDO_0004733) (pyriform sinus cancer), [MONDO:0001743](http://purl.obolibrary.org/obo/MONDO_0001743) (paranasal sinus lymphoma), [MONDO:0000534](http://purl.obolibrary.org/obo/MONDO_0000534) (trachea mucoepidermoid carcinoma), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0004973](http://purl.obolibrary.org/obo/MONDO_0004973) (adenosquamous lung carcinoma), [MONDO:0006998](http://purl.obolibrary.org/obo/MONDO_0006998) (tonsil cancer), [MONDO:0004611](http://purl.obolibrary.org/obo/MONDO_0004611) (soft palate cancer), [MONDO:0000375](http://purl.obolibrary.org/obo/MONDO_0000375) (bronchus carcinoma in situ), [MONDO:0001861](http://purl.obolibrary.org/obo/MONDO_0001861) (malignant parietal pleura tumor), [MONDO:0004696](http://purl.obolibrary.org/obo/MONDO_0004696) (larynx carcinoma in situ), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0000893](http://purl.obolibrary.org/obo/MONDO_0000893) (mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0004332](http://purl.obolibrary.org/obo/MONDO_0004332) (lung hilum cancer), [MONDO:0000372](http://purl.obolibrary.org/obo/MONDO_0000372) (pharynx carcinoma in situ), [MONDO:0006352](http://purl.obolibrary.org/obo/MONDO_0006352) (paranasal sinus adenoid cystic carcinoma), [MONDO:0004690](http://purl.obolibrary.org/obo/MONDO_0004690) (tonsillar fossa cancer), [MONDO:0004295](http://purl.obolibrary.org/obo/MONDO_0004295) (asbestos-related lung carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0006471](http://purl.obolibrary.org/obo/MONDO_0006471) (tracheal adenoid cystic carcinoma), [MONDO:0004293](http://purl.obolibrary.org/obo/MONDO_0004293) (supraglottis squamous cell carcinoma), [MONDO:0006470](http://purl.obolibrary.org/obo/MONDO_0006470) (tonsillar squamous cell carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0004291](http://purl.obolibrary.org/obo/MONDO_0004291) (subglottis squamous cell carcinoma), [MONDO:0001756](http://purl.obolibrary.org/obo/MONDO_0001756) (frontal sinus cancer), [MONDO:0021345](http://purl.obolibrary.org/obo/MONDO_0021345) (carcinoma of pharynx), [MONDO:0001758](http://purl.obolibrary.org/obo/MONDO_0001758) (paranasal sinus sarcoma), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0001994](http://purl.obolibrary.org/obo/MONDO_0001994) (sphenoidal sinus cancer), [MONDO:0006407](http://purl.obolibrary.org/obo/MONDO_0006407) (sarcomatoid mesothelioma), [MONDO:0002448](http://purl.obolibrary.org/obo/MONDO_0002448) (larynx sarcoma), [MONDO:0004624](http://purl.obolibrary.org/obo/MONDO_0004624) (uvula cancer), [MONDO:0004500](http://purl.obolibrary.org/obo/MONDO_0004500) (lung superior sulcus carcinoma), [MONDO:0000380](http://purl.obolibrary.org/obo/MONDO_0000380) (paranasal sinus cancer), [MONDO:0006367](http://purl.obolibrary.org/obo/MONDO_0006367) (pharyngeal adenoid cystic carcinoma), [MONDO:0003374](http://purl.obolibrary.org/obo/MONDO_0003374) (larynx leiomyosarcoma), [MONDO:0006883](http://purl.obolibrary.org/obo/MONDO_0006883) (Pancoast tumor), [MONDO:0003892](http://purl.obolibrary.org/obo/MONDO_0003892) (acinar lung adenocarcinoma), [MONDO:0003095](http://purl.obolibrary.org/obo/MONDO_0003095) (laryngeal mucoepidermoid carcinoma), [MONDO:0005806](http://purl.obolibrary.org/obo/MONDO_0005806) (hypopharynx cancer), [MONDO:0001724](http://purl.obolibrary.org/obo/MONDO_0001724) (supraglottis cancer), [MONDO:0003904](http://purl.obolibrary.org/obo/MONDO_0003904) (lung occult squamous cell carcinoma), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0002418](http://purl.obolibrary.org/obo/MONDO_0002418) (ethmoid sinus adenocarcinoma), [MONDO:0003987](http://purl.obolibrary.org/obo/MONDO_0003987) (lung lymphoma), [MONDO:0021337](http://purl.obolibrary.org/obo/MONDO_0021337) (tonsil carcinoma), [MONDO:0002811](http://purl.obolibrary.org/obo/MONDO_0002811) (main bronchus cancer), [MONDO:0003588](http://purl.obolibrary.org/obo/MONDO_0003588) (larynx liposarcoma), [MONDO:0004556](http://purl.obolibrary.org/obo/MONDO_0004556) (carcinoma arising in nasal papillomatosis), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0021298](http://purl.obolibrary.org/obo/MONDO_0021298) (carcinoma in situ of oropharynx), [MONDO:0021297](http://purl.obolibrary.org/obo/MONDO_0021297) (carcinoma in situ of nasopharynx), [MONDO:0006297](http://purl.obolibrary.org/obo/MONDO_0006297) (maxillary sinus adenoid cystic carcinoma), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0003181](http://purl.obolibrary.org/obo/MONDO_0003181) (lung adenoid cystic carcinoma), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma, susceptibility to, 1), [MONDO:0003184](http://purl.obolibrary.org/obo/MONDO_0003184) (trachea carcinoma), [MONDO:0006294](http://purl.obolibrary.org/obo/MONDO_0006294) (pleural cancer), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharyngeal carcinoma), [MONDO:0006292](http://purl.obolibrary.org/obo/MONDO_0006292) (malignant mesothelioma (disease)), [MONDO:0021329](http://purl.obolibrary.org/obo/MONDO_0021329) (carcinoma of soft palate), [MONDO:0000407](http://purl.obolibrary.org/obo/MONDO_0000407) (malignant pleural solitary fibrous tumor), [MONDO:0019122](http://purl.obolibrary.org/obo/MONDO_0019122) (idiopathic acute eosinophilic pneumonia), [MONDO:0004607](http://purl.obolibrary.org/obo/MONDO_0004607) (vallecula cancer), [MONDO:0021288](http://purl.obolibrary.org/obo/MONDO_0021288) (carcinoma in situ of hypopharynx), [MONDO:0004608](http://purl.obolibrary.org/obo/MONDO_0004608) (oropharynx cancer), [MONDO:0003638](http://purl.obolibrary.org/obo/MONDO_0003638) (lung meningioma), [MONDO:0004328](http://purl.obolibrary.org/obo/MONDO_0004328) (maxillary sinus adenocarcinoma), [MONDO:0004205](http://purl.obolibrary.org/obo/MONDO_0004205) (lymphohistiocytoid mesothelioma), [MONDO:0002426](http://purl.obolibrary.org/obo/MONDO_0002426) (lung sarcoma), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0006109](http://purl.obolibrary.org/obo/MONDO_0006109) (malignant biphasic mesothelioma), [MONDO:0005138](http://purl.obolibrary.org/obo/MONDO_0005138) (lung carcinoma), [MONDO:0003357](http://purl.obolibrary.org/obo/MONDO_0003357) (lung leiomyosarcoma), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0004685](http://purl.obolibrary.org/obo/MONDO_0004685) (Waldeyer's ring cancer), [MONDO:0001293](http://purl.obolibrary.org/obo/MONDO_0001293) (subglottis cancer), [MONDO:0021287](http://purl.obolibrary.org/obo/MONDO_0021287) (carcinoma in situ of epiglottis), [MONDO:0001691](http://purl.obolibrary.org/obo/MONDO_0001691) (laryngeal cartilage cancer), [MONDO:0005097](http://purl.obolibrary.org/obo/MONDO_0005097) (squamous cell lung carcinoma), [MONDO:0016644](http://purl.obolibrary.org/obo/MONDO_0016644) (Logopenic progressive aphasia), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0002358](http://purl.obolibrary.org/obo/MONDO_0002358) (laryngeal carcinoma), [MONDO:0021315](http://purl.obolibrary.org/obo/MONDO_0021315) (malignant tumor of nasopharynx), [MONDO:0017292](http://purl.obolibrary.org/obo/MONDO_0017292) (well-differentiated fetal adenocarcinoma of the lung), [MONDO:0008903](http://purl.obolibrary.org/obo/MONDO_0008903) (lung cancer), [MONDO:0002355](http://purl.obolibrary.org/obo/MONDO_0002355) (glottis carcinoma), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0004499](http://purl.obolibrary.org/obo/MONDO_0004499) (hilar lung carcinoma), [MONDO:0006279](http://purl.obolibrary.org/obo/MONDO_0006279) (lung sarcomatoid carcinoma), [MONDO:0006277](http://purl.obolibrary.org/obo/MONDO_0006277) (lung lymphangioleiomyomatosis), [MONDO:0002352](http://purl.obolibrary.org/obo/MONDO_0002352) (larynx cancer), [MONDO:0006276](http://purl.obolibrary.org/obo/MONDO_0006276) (lung inflammatory myofibroblastic tumor), [MONDO:0002351](http://purl.obolibrary.org/obo/MONDO_0002351) (glottis cancer), [MONDO:0006275](http://purl.obolibrary.org/obo/MONDO_0006275) (lung giant cell carcinoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0005061](http://purl.obolibrary.org/obo/MONDO_0005061) (lung adenocarcinoma), [MONDO:0002806](http://purl.obolibrary.org/obo/MONDO_0002806) (bronchus carcinoma), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0021300](http://purl.obolibrary.org/obo/MONDO_0021300) (adenoid cystic carcinoma of oropharynx), [MONDO:0000503](http://purl.obolibrary.org/obo/MONDO_0000503) (in situ pulmonary adenocarcinoma), [MONDO:0005517](http://purl.obolibrary.org/obo/MONDO_0005517) (pharynx cancer), [MONDO:0006329](http://purl.obolibrary.org/obo/MONDO_0006329) (olfactory neuroblastoma), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0001672](http://purl.obolibrary.org/obo/MONDO_0001672) (bronchus cancer), [MONDO:0005512](http://purl.obolibrary.org/obo/MONDO_0005512) (malignant peritoneal mesothelioma), [MONDO:0003212](http://purl.obolibrary.org/obo/MONDO_0003212) (nasal cavity carcinoma), [MONDO:0003211](http://purl.obolibrary.org/obo/MONDO_0003211) (nasal cavity adenocarcinoma), [MONDO:0006049](http://purl.obolibrary.org/obo/MONDO_0006049) (papillary lung adenocarcinoma), [MONDO:0005599](http://purl.obolibrary.org/obo/MONDO_0005599) (malignant epithelioid mesothelioma), [MONDO:0004661](http://purl.obolibrary.org/obo/MONDO_0004661) (trachea carcinoma in situ), [MONDO:0005112](http://purl.obolibrary.org/obo/MONDO_0005112) (malignant pleural mesothelioma), [MONDO:0005233](http://purl.obolibrary.org/obo/MONDO_0005233) (non-small cell lung carcinoma (disease)), [MONDO:0006201](http://purl.obolibrary.org/obo/MONDO_0006201) (ethmoid sinus adenoid cystic carcinoma), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0004660](http://purl.obolibrary.org/obo/MONDO_0004660) (lung carcinoma in situ), [MONDO:0005595](http://purl.obolibrary.org/obo/MONDO_0005595) (laryngeal squamous cell carcinoma), [MONDO:0003050](http://purl.obolibrary.org/obo/MONDO_0003050) (lung large cell carcinoma), [MONDO:0012159](http://purl.obolibrary.org/obo/MONDO_0012159) (LNCR1), [MONDO:0006281](http://purl.obolibrary.org/obo/MONDO_0006281) (lung signet ring cell carcinoma), [MONDO:0012955](http://purl.obolibrary.org/obo/MONDO_0012955) (LNCR4), [MONDO:0006280](http://purl.obolibrary.org/obo/MONDO_0006280) (lung sclerosing hemangioma), [MONDO:0013631](http://purl.obolibrary.org/obo/MONDO_0013631) (LNCR5), [MONDO:0018761](http://purl.obolibrary.org/obo/MONDO_0018761) (SMARCA4-deficient sarcoma of thorax), [MONDO:0001129](http://purl.obolibrary.org/obo/MONDO_0001129) (nasal cavity olfactory neuroblastoma), [MONDO:0001407](http://purl.obolibrary.org/obo/MONDO_0001407) (tracheal cancer), [MONDO:0004637](http://purl.obolibrary.org/obo/MONDO_0004637) (aryepiglottic fold cancer), [MONDO:0001763](http://purl.obolibrary.org/obo/MONDO_0001763) (ethmoid sinus cancer), [MONDO:0001128](http://purl.obolibrary.org/obo/MONDO_0001128) (nasal cavity cancer), [MONDO:0021537](http://purl.obolibrary.org/obo/MONDO_0021537) (undifferentiated carcinoma of nasopharynx), [MONDO:0004635](http://purl.obolibrary.org/obo/MONDO_0004635) (postcricoid region cancer), [MONDO:0004357](http://purl.obolibrary.org/obo/MONDO_0004357) (carcinoma of supraglottis), [MONDO:0004358](http://purl.obolibrary.org/obo/MONDO_0004358) (subglottis carcinoma), [MONDO:0004237](http://purl.obolibrary.org/obo/MONDO_0004237) (large cell carcinoma with rhabdoid phenotype), [MONDO:0003784](http://purl.obolibrary.org/obo/MONDO_0003784) (nasal cavity carcinoma in situ), [MONDO:0004991](http://purl.obolibrary.org/obo/MONDO_0004991) (bronchoalveolar adenocarcinoma), [MONDO:0006378](http://purl.obolibrary.org/obo/MONDO_0006378) (pleural epithelioid mesothelioma), [MONDO:0006377](http://purl.obolibrary.org/obo/MONDO_0006377) (pleural biphasic mesothelioma), [MONDO:0004473](http://purl.obolibrary.org/obo/MONDO_0004473) (epiglottis cancer), [MONDO:0012942](http://purl.obolibrary.org/obo/MONDO_0012942) (LNCR3), [MONDO:0001419](http://purl.obolibrary.org/obo/MONDO_0001419) (trachea squamous cell carcinoma), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0001418](http://purl.obolibrary.org/obo/MONDO_0001418) (trachea sarcoma), [MONDO:0001417](http://purl.obolibrary.org/obo/MONDO_0001417) (tracheal lymphoma), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0005616](http://purl.obolibrary.org/obo/MONDO_0005616) (pulmonary mucoepidermoid carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0004128](http://purl.obolibrary.org/obo/MONDO_0004128) (lung occult large cell carcinoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0005216](http://purl.obolibrary.org/obo/MONDO_0005216) (hypopharyngeal carcinoma), [MONDO:0004127](http://purl.obolibrary.org/obo/MONDO_0004127) (lung occult adenocarcinoma), [MONDO:0002223](http://purl.obolibrary.org/obo/MONDO_0002223) (ovarian malignant mesothelioma), [MONDO:0004642](http://purl.obolibrary.org/obo/MONDO_0004642) (tonsillar pillar cancer), [MONDO:0004087](http://purl.obolibrary.org/obo/MONDO_0004087) (basaloid lung carcinoma), [MONDO:0006024](http://purl.obolibrary.org/obo/MONDO_0006024) (anaplastic lung carcinoma), [MONDO:0001130](http://purl.obolibrary.org/obo/MONDO_0001130) (nasal cavity lymphoma), [MONDO:0006265](http://purl.obolibrary.org/obo/MONDO_0006265) (laryngeal small cell carcinoma), [MONDO:0006264](http://purl.obolibrary.org/obo/MONDO_0006264) (laryngeal adenoid cystic carcinoma), [MONDO:0006380](http://purl.obolibrary.org/obo/MONDO_0006380) (pleural sarcomatoid mesothelioma), [MONDO:0004080](http://purl.obolibrary.org/obo/MONDO_0004080) (glottis squamous cell carcinoma), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0071375](http://purl.obolibrary.org/obo/GO_0071375) (cellular response to peptide hormone stimulus), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:0097527](http://purl.obolibrary.org/obo/GO_0097527) (necroptotic signaling pathway), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0050688](http://purl.obolibrary.org/obo/GO_0050688) (regulation of defense response to virus), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0048388](http://purl.obolibrary.org/obo/GO_0048388) (endosomal lumen acidification), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:2000270](http://purl.obolibrary.org/obo/GO_2000270) (negative regulation of fibroblast apoptotic process), [GO:2001241](http://purl.obolibrary.org/obo/GO_2001241) (positive regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:2001233](http://purl.obolibrary.org/obo/GO_2001233) (regulation of apoptotic signaling pathway), [GO:0035005](http://purl.obolibrary.org/obo/GO_0035005) (1-phosphatidylinositol-4-phosphate 3-kinase activity), [GO:0060561](http://purl.obolibrary.org/obo/GO_0060561) (apoptotic process involved in morphogenesis), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0019838](http://purl.obolibrary.org/obo/GO_0019838) (growth factor binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0070243](http://purl.obolibrary.org/obo/GO_0070243) (regulation of thymocyte apoptotic process), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0014037](http://purl.obolibrary.org/obo/GO_0014037) (Schwann cell differentiation), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:0048696](http://purl.obolibrary.org/obo/GO_0048696) (regulation of collateral sprouting in absence of injury), [GO:0047485](http://purl.obolibrary.org/obo/GO_0047485) (protein N-terminus binding), [GO:0070231](http://purl.obolibrary.org/obo/GO_0070231) (T cell apoptotic process), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0060347](http://purl.obolibrary.org/obo/GO_0060347) (heart trabecula formation), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0070266](http://purl.obolibrary.org/obo/GO_0070266) (necroptotic process), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0060333](http://purl.obolibrary.org/obo/GO_0060333) (interferon-gamma-mediated signaling pathway), [GO:1903514](http://purl.obolibrary.org/obo/GO_1903514) (release of sequestered calcium ion into cytosol by endoplasmic reticulum), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0045084](http://purl.obolibrary.org/obo/GO_0045084) (positive regulation of interleukin-12 biosynthetic process), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0072554](http://purl.obolibrary.org/obo/GO_0072554) (blood vessel lumenization), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0045088](http://purl.obolibrary.org/obo/GO_0045088) (regulation of innate immune response), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0071347](http://purl.obolibrary.org/obo/GO_0071347) (cellular response to interleukin-1), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0042532](http://purl.obolibrary.org/obo/GO_0042532) (negative regulation of tyrosine phosphorylation of STAT protein), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0032728](http://purl.obolibrary.org/obo/GO_0032728) (positive regulation of interferon-beta production), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0014044](http://purl.obolibrary.org/obo/GO_0014044) (Schwann cell development), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0032825](http://purl.obolibrary.org/obo/GO_0032825) (positive regulation of natural killer cell differentiation), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0030644](http://purl.obolibrary.org/obo/GO_0030644) (cellular chloride ion homeostasis), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0009636](http://purl.obolibrary.org/obo/GO_0009636) (response to toxic substance), [GO:0097200](http://purl.obolibrary.org/obo/GO_0097200) (cysteine-type endopeptidase activity involved in execution phase of apoptosis), [GO:0097202](http://purl.obolibrary.org/obo/GO_0097202) (activation of cysteine-type endopeptidase activity), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0004197](http://purl.obolibrary.org/obo/GO_0004197) (cysteine-type endopeptidase activity), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0030690](http://purl.obolibrary.org/obo/GO_0030690) (Noc1p-Noc2p complex), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0048919](http://purl.obolibrary.org/obo/GO_0048919) (posterior lateral line neuromast development), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006283](http://purl.obolibrary.org/obo/GO_0006283) (transcription-coupled nucleotide-excision repair), [GO:0007256](http://purl.obolibrary.org/obo/GO_0007256) (activation of JNKK activity), [GO:0007257](http://purl.obolibrary.org/obo/GO_0007257) (activation of JUN kinase activity), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0048914](http://purl.obolibrary.org/obo/GO_0048914) (myelination of anterior lateral line nerve axons), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0032449](http://purl.obolibrary.org/obo/GO_0032449) (CBM complex), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0045651](http://purl.obolibrary.org/obo/GO_0045651) (positive regulation of macrophage differentiation), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0006290](http://purl.obolibrary.org/obo/GO_0006290) (pyrimidine dimer repair), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0001837](http://purl.obolibrary.org/obo/GO_0001837) (epithelial to mesenchymal transition), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0070507](http://purl.obolibrary.org/obo/GO_0070507) (regulation of microtubule cytoskeleton organization), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0048932](http://purl.obolibrary.org/obo/GO_0048932) (myelination of posterior lateral line nerve axons), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0043374](http://purl.obolibrary.org/obo/GO_0043374) (CD8-positive, alpha-beta T cell differentiation), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0032784](http://purl.obolibrary.org/obo/GO_0032784) (regulation of DNA-templated transcription, elongation), [GO:0032786](http://purl.obolibrary.org/obo/GO_0032786) (positive regulation of DNA-templated transcription, elongation), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0097199](http://purl.obolibrary.org/obo/GO_0097199) (cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0008023](http://purl.obolibrary.org/obo/GO_0008023) (transcription elongation factor complex), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0046934](http://purl.obolibrary.org/obo/GO_0046934) (phosphatidylinositol-4,5-bisphosphate 3-kinase activity), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0035877](http://purl.obolibrary.org/obo/GO_0035877) (death effector domain binding), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0042101](http://purl.obolibrary.org/obo/GO_0042101) (T cell receptor complex), [GO:0000303](http://purl.obolibrary.org/obo/GO_0000303) (response to superoxide), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030296](http://purl.obolibrary.org/obo/GO_0030296) (protein tyrosine kinase activator activity), [GO:0031264](http://purl.obolibrary.org/obo/GO_0031264) (death-inducing signaling complex), [GO:0031265](http://purl.obolibrary.org/obo/GO_0031265) (CD95 death-inducing signaling complex), [GO:0010224](http://purl.obolibrary.org/obo/GO_0010224) (response to UV-B), [GO:0045629](http://purl.obolibrary.org/obo/GO_0045629) (negative regulation of T-helper 2 cell differentiation), [GO:0045627](http://purl.obolibrary.org/obo/GO_0045627) (positive regulation of T-helper 1 cell differentiation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0045742](http://purl.obolibrary.org/obo/GO_0045742) (positive regulation of epidermal growth factor receptor signaling pathway), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045862](http://purl.obolibrary.org/obo/GO_0045862) (positive regulation of proteolysis), [GO:0097153](http://purl.obolibrary.org/obo/GO_0097153) (cysteine-type endopeptidase activity involved in apoptotic process), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0002819](http://purl.obolibrary.org/obo/GO_0002819) (regulation of adaptive immune response), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0097284](http://purl.obolibrary.org/obo/GO_0097284) (hepatocyte apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0045494](http://purl.obolibrary.org/obo/GO_0045494) (photoreceptor cell maintenance), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0032285](http://purl.obolibrary.org/obo/GO_0032285) (non-myelinated axon ensheathment), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:2000653](http://purl.obolibrary.org/obo/GO_2000653) (regulation of genetic imprinting), [GO:0032147](http://purl.obolibrary.org/obo/GO_0032147) (activation of protein kinase activity), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0060416](http://purl.obolibrary.org/obo/GO_0060416) (response to growth hormone), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0019051](http://purl.obolibrary.org/obo/GO_0019051) (induction by virus of host apoptotic process), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle), [GO:0023014](http://purl.obolibrary.org/obo/GO_0023014) (signal transduction by protein phosphorylation), [GO:0005943](http://purl.obolibrary.org/obo/GO_0005943) (phosphatidylinositol 3-kinase complex, class IA), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0046666](http://purl.obolibrary.org/obo/GO_0046666) (retinal cell programmed cell death), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0006925](http://purl.obolibrary.org/obo/GO_0006925) (inflammatory cell apoptotic process), [GO:2000564](http://purl.obolibrary.org/obo/GO_2000564) (regulation of CD8-positive, alpha-beta T cell proliferation), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0001208](http://purl.obolibrary.org/obo/GO_0001208) (histone H2A-H2B dimer displacement), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0045590](http://purl.obolibrary.org/obo/GO_0045590) (negative regulation of regulatory T cell differentiation), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0004716](http://purl.obolibrary.org/obo/GO_0004716) (signal transducer, downstream of receptor, with protein tyrosine kinase activity), [GO:0034124](http://purl.obolibrary.org/obo/GO_0034124) (regulation of MyD88-dependent toll-like receptor signaling pathway), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:0031098](http://purl.obolibrary.org/obo/GO_0031098) (stress-activated protein kinase signaling cascade), [GO:0044029](http://purl.obolibrary.org/obo/GO_0044029) (hypomethylation of CpG island), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0046696](http://purl.obolibrary.org/obo/GO_0046696) (lipopolysaccharide receptor complex), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), 

**Class expressions from DL-Learner:**

- Thing 57.43%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.37%
- [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton) 50.37%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 50.37%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 50.37%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 50.37%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.37%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.42%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.73%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 35.73%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 35.73%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 35.73%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 35.73%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005013](http://purl.obolibrary.org/obo/GO_0005013) (obsolete neurotrophin TRK receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.73%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005012](http://purl.obolibrary.org/obo/GO_0005012) (obsolete Neu/ErbB-2 receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.73%


